Macrophage scavenger receptor a mediates adhesion to apolipoproteins A-I and E

Biochemistry

Volumn 48, Issue 50, 2009, Pages 11858-11871

  Neyen, Claudine ^a   Plüddemann, Annette ^a   Roversi, Pietro ^a   Thomas, Benjamin ^a   Cai, Lei ^c   Van Der Westhuyzen, Deneys R ^c   Sim, Robert B ^b   Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; AGE-RELATED; ALZHEIMER'S; ALZHEIMER'S DISEASE; AMPHIPATHIC; APOLIPOPROTEINS A-I; APOPTOTIC CELLS; ATHEROSCLEROTIC LESIONS; EXTRACELLULAR MATRIX PROTEIN; HIGH-THROUGHPUT; INNATE IMMUNITY; INTEGRINS; MACROPHAGE ADHESION; MICROENVIRONMENTS; PATTERN RECOGNITION RECEPTORS; POLYANIONICS; SCAVENGER RECEPTOR; SCREENING METHODS;

ADHESION; DISEASES; ENZYME ACTIVITY; LIGANDS; PATHOLOGY; PATTERN RECOGNITION; PROTEINS;

MACROPHAGES;

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; INTEGRIN; LIGAND; LIPID; SCAVENGER RECEPTOR A;

ADHESION; ALPHA HELIX; ARTICLE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; SCREENING;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; CELL LINE; HUMANS; LIGANDS; MACROPHAGES; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SCAVENGER RECEPTORS, CLASS A;

EID: 72449166872     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9013769     Document Type: Article

References (86)

1. Goldstein, J. L., Ho, Y. K., Basu, S. K., and Brown, M. S. (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U.S.A. 76, 333-337.
2. Brown, M. S., Basu, S. K., Falck, J. R., Ho, Y. K., and Goldstein, J. L. (1980) The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively- charged LDL by macrophages. J. Supramol. Struct. 13, 67-81.
3. Kodama, T., Reddy, P., Kishimoto, C., and Krieger, M. (1988) Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc. Natl. Acad. Sci. U.S.A. 85, 9238-9242.
4. Naito, M., Kodama, T., Matsumoto, A., Doi, T., and Takahashi, K. (1991) Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am. J. Pathol. 139, 1411-1423.
5. Krieger, M., Acton, S., Ashkenas, J., Pearson, A., Penman, M., and Resnick, D. (1993) Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268, 4569-4572.
6. Horiuchi, S., Sakamoto, Y., and Sakai, M. (2003) Scavenger receptors for oxidized and glycated proteins. Amino Acids 25, 283-292. (Pubitemid 38041266)
7. Husemann, J., Loike, J. D., Anankov, R., Febbraio, M., and Silverstein, S. C. (2002) Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system. Glia 40, 195-205. (Pubitemid 35337377)
8. Acton, S., Resnick, D., Freeman, M., Ekkel, Y., Ashkenas, J., and Krieger, M. (1993) The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J. Biol. Chem. 268, 3530-3537.
9. Doi, T., Higashino, K., Kurihara, Y., Wada, Y., Miyazaki, T., Nakamura, H., Uesugi, S., Imanishi, T., Kawabe, Y., and Itakura, H.; et al. (1993) Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J. Biol. Chem. 268, 2126-2133.
10. Doi, T., Kurasawa, M., Higashino, K., Imanishi, T., Mori, T., Naito, M., Takahashi, K., Kawabe, Y., Wada, Y., and Matsumoto, A.; et al. (1994) The histidine interruption of an R-helical coiled coil allosterically mediates a pH-dependent ligand dissociation from macrophage scavenger receptors. J. Biol. Chem. 269, 25598-25604.
11. Mommaas-Kienhuis, A. M., van der Schroeff, J. G., Wijsman, M. C., Daems, W. T., and Vermeer, B. J. (1985) Conjugates of colloidal gold with native and acetylated low density lipoproteins for ultrastructural investigations on receptor-mediated endocytosis by cultured human monocyte-derived macrophages. Histochemistry 83, 29-35.
12. Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M., and Horiuchi, S. (1995) Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem. 230, 408-415.
13. Yong, K., and Khwaja, A. (1990) Leucocyte cellular adhesion molecules. Blood Rev. 4, 211-225.
14. Plüddemann, A., Neyen, C., and Gordon, S. (2007) Macrophage scavenger receptors and host-derived ligands. Methods 43, 207-217. (Pubitemid 47499075)
15. Usui, H. K., Shikata, K., Sasaki, M., Okada, S., Matsuda, M., Shikata, Y., Ogawa, D., Kido, Y., Nagase, R., Yozai, K., Ohga, S., Tone, A., Wada, J., Takeya, M., Horiuchi, S., Kodama, T., and Makino, H. (2007) Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes 56, 363-372. (Pubitemid 46263074)
16. Fraser, I., Hughes, D., and Gordon, S. (1993) Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364, 343-346. (Pubitemid 23265276)
17. El Khoury, J., Thomas, C. A., Loike, J. D., Hickman, S. E., Cao, L., and Silverstein, S. C. (1994) Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J. Biol. Chem. 269, 10197-10200.
18. Gowen, B. B., Borg, T. K., Ghaffar, A., and Mayer, E. P. (2000) Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol. 19, 61-71. (Pubitemid 30109396)
19. Santiago-Garcia, J., Kodama, T., and Pitas, R. E. (2003) The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J. Biol. Chem. 278, 6942-6946.
20. Plüddemann, A., Neyen, C., Gordon, S., and Peiser, L. (2008) A sensitive solid-phase assay for identification of class A macrophage scavenger receptor ligands using cell lysate. J. Immunol. Methods 329, 167-175. (Pubitemid 350245504)
21. de Villiers, W. J., Fraser, I. P., Hughes, D. A., Doyle, A. G., and Gordon, S. (1994) Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180, 705-709.
22. Ashkenas, J., Penman, M., Vasile, E., Acton, S., Freeman, M., and Krieger, M. (1993) Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J. Lipid Res. 34, 983-1000. (Pubitemid 23182696)
23. Butler, P. J., Harris, J. I., Hartley, B. S., and Lebeman, R. (1969) The use of maleic anhydride for the reversible blocking of amino groups in polypeptide chains. Biochem. J. 112, 679-689.
24. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
25. Pappin, D. J., Hojrup, P., and Bleasby, A. J. (1993) Rapid identification of proteins by peptide-mass fingerprinting. Curr. Biol. 3, 327-332.
26. Sim, R. B., Day, A. J., Moffatt, B. E., and Fontaine, M. (1993) Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 223, 13-35. (Pubitemid 23321177)
27. Poumay, Y., and Ronveaux-Dupal, M. F. (1985) Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient ultracentrifugation. J. Lipid Res. 26, 1476-1480. (Pubitemid 16189745)
28. Jaroszewski, L., Rychlewski, L., Li, Z., Li, W., and Godzik, A. (2005) FFAS03: A server for profile-profile sequence alignments. Nucleic Acids Res. 33, W284-W288. (Pubitemid 44529927)
29. Canutescu, A. A., Shelenkov, A. A., and Dunbrack, R. L. Jr. (2003) A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci. 12, 2001-2014.
30. Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M. Y., Pieper, U., and Sali, A. (2007) Comparative protein structure modeling using MODELLER. Current Protocols in Protein Science , Chapter 2, Unit 2, p 9, Wiley, New York.
31. Dominguez, C., Boelens, R., and Bonvin, A. M. (2003) HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125, 1731-1737.
32. Krissinel, E., and Henrick, K. (2007) Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774-797.
33. Kontush, A., de Faria, E. C., Chantepie, S., and Chapman, M. J. (2005) A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182, 277-285. (Pubitemid 41267195)
34. Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., Chea, H., Knopp, R. H., Brunzell, J., Geary, R., Chait, A., Zhao, X. Q., Elkon, K., Marcovina, S., Ridker, P., Oram, J. F., and Heinecke, J. W. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117, 746-756.
35. Suc, I., Brunet, S., Mitchell, G., Rivard, G. E., and Levy, E. (2003) Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: Role of scavenger receptors, classes A and B. J. Cell Sci. 116, 89-99. (Pubitemid 36113968)
36. Bolanos-Garcia, V. M., and Miguel, R. N. (2003) On the structure and function of apolipoproteins: More than a family of lipid-binding proteins. Prog. Biophys. Mol. Biol. 83, 47-68.
37. Shao, B., Oda, M. N., Bergt, C., Fu, X., Green, P. S., Brot, N., Oram, J. F., and Heinecke, J. W. (2006) Myeloperoxidase impairs ABCA1- dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J. Biol. Chem. 281, 9001-9004.
38. Nagai, R., Matsumoto, K., Ling, X., Suzuki, H., Araki, T., and Horiuchi, S. (2000) Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49, 1714-1723. (Pubitemid 30746050)
39. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716-719. (Pubitemid 26282177)
40. Mucchiano, G. I., Jonasson, L., Haggqvist, B., Einarsson, E., and Westermark, P. (2001) Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol. Am. J. Clin. Pathol. 115, 298-303.
41. Harr, S. D., Uint, L., Hollister, R., Hyman, B. T., and Mendez, A. J. (1996) Brain expression of apolipoproteins E, J, and A-I in Alzheimer0s disease. J. Neurochem. 66, 2429-2435. (Pubitemid 26159078)
42. Wisniewski, T., Golabek, A. A., Kida, E., Wisniewski, K. E., and Frangione, B. (1995) Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am. J. Pathol. 147, 238-244.
43. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., and Roses, A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90, 9649-9653.
44. Werb, Z., and Chin, J. R. (1983) Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes. J. Cell Biol. 97, 1113-1118.
45. Yamamoto, K., Nishimura, N., Doi, T., Imanishi, T., Kodama, T., Suzuki, K., and Tanaka, T. (1997) The lysine cluster in the collagen-like domain of the scavenger receptor provides for its ligand binding and ligand specificity. FEBS Lett. 414, 182-186. (Pubitemid 27389359)
46. Narayanaswami, V., and Ryan, R. O. (2000) Molecular basis of exchangeable apolipoprotein function. Biochim. Biophys. Acta 1483, 15-36.
47. Ajees, A. A., Anantharamaiah, G. M., Mishra, V. K., Hussain, M. M., and Murthy, H. M. (2006) Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 103, 2126-2131.
48. Navab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Wagner, A. C., Frank, J. S., Datta, G., Garber, D., and Fogelman, A. M. (2004) Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109, 3215-3220.
49. Navab, M., Anantharamaiah, G. M., Hama, S., Hough, G., Reddy, S. T., Frank, J. S., Garber, D. W., Handattu, S., and Fogelman, A. M. (2005) D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 25, 1426-1432.
50. Navab, M., Anantharamaiah, G. M., Hama, S., Garber, D. W., Chaddha, M., Hough, G., Lallone, R., and Fogelman, A. M. (2002) Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105, 290-292. (Pubitemid 34106174)
51. Van Lenten, B. J., Wagner, A. C., Navab, M., Anantharamaiah, G. M., Hui, E. K., Nayak, D. P., and Fogelman, A. M. (2004) D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 110, 3252-3258. (Pubitemid 39525074)
52. Navab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Yu, N., Ansell, B. J., Datta, G., Garber, D. W., and Fogelman, A. M. (2005) Apolipoprotein A-I mimetic peptides. Arterioscler. Thromb. Vasc. Biol. 25, 1325-1331.
53. Soulages, J. L., and Arrese, E. L. (2000) Dynamics and hydration of the α-helices of apolipophorin III. J. Biol. Chem. 275, 17501-17509.
54. Wang, J., Sykes, B. D., and Ryan, R. O. (2002) Structural basis for the conformational adaptability of apolipophorin III, a helix-bundle exchangeable apolipoprotein. Proc. Natl. Acad. Sci. U.S.A. 99, 1188-1193.
55. Freeman, M., Ekkel, Y., Rohrer, L., Penman, M., Freedman, N. J., Chisolm, G. M., and Krieger, M. (1991) Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: Lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U.S. A. 88, 4931-4935.
56. Wright, S. D., Reddy, P. A., Jong, M. T., and Erickson, B. W. (1987) C3bi receptor (complement receptor type 3) recognizes a region of complement protein C3 containing the sequence Arg-Gly-Asp. Proc. Natl. Acad. Sci. U.S.A. 84, 1965-1968.
57. Kosswig, N., Rice, S., Daugherty, A., and Post, S. R. (2003) Class A scavenger receptor-mediated adhesion and internalization require distinct cytoplasmic domains. J. Biol. Chem. 278, 34219-34225.
58. Whitman, S. C., Daugherty, A., and Post, S. R. (2000) Regulation of acetylated low density lipoprotein uptake in macrophages by pertussis toxin-sensitive G proteins. J. Lipid Res. 41, 807-813. (Pubitemid 30314136)
59. Post, S. R., Gass, C., Rice, S., Nikolic, D., Crump, H., and Post, G. R. (2002) Class A scavenger receptors mediate cell adhesion via activation of G(i/o) and formation of focal adhesion complexes. J. Lipid Res. 43, 1829-1836. (Pubitemid 35315800)
60. Gough, P. J., Greaves, D. R., Suzuki, H., Hakkinen, T., Hiltunen, M. O., Turunen, M., Herttuala, S. Y., Kodama, T., and Gordon, S. (1999) Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19, 461-471.
61. Alarcon, R., Fuenzalida, C., Santibanez, M., and von Bernhardi, R. (2005) Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound β-amyloid. J. Biol. Chem. 280, 30406-30415.
62. Park, Y. M., Febbraio, M., and Silverstein, R. L. (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119, 136-145.
63. Manning-Tobin, J. J., Moore, K. J., Seimon, T. A., Bell, S. A., Sharuk, M., Alvarez-Leite, J. I., de Winther, M. P., Tabas, I., and Freeman, M. W. (2009) Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 29, 19-26.
64. Moore, K. J., Kunjathoor, V. V., Koehn, S. L., Manning, J. J., Tseng, A. A., Silver, J. M., McKee, M., and Freeman, M. W. (2005) Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 115, 2192-2201.
65. Nikolic, D. M., Cholewa, J., Gass, C., Gong, M. C., and Post, S. R. (2007) Class A scavenger receptor-mediated cell adhesion requires the sequential activation of Lyn and PI3-kinase. Am. J. Physiol. 292, C1450-C1458.
66. Nikolic, D. M., Gong, M. C., Turk, J., and Post, S. R. (2007) Class A scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A2 and 12/15-lipoxygenase to Rac and Cdc42 activation. J. Biol. Chem. 282, 33405-33411.
67. Moore, K. J., El Khoury, J., Medeiros, L. A., Terada, K., Geula, C., Luster, A. D., and Freeman, M. W. (2002)ACD36-initiated signaling cascade mediates inflammatory effects of β-amyloid. J. Biol. Chem. 277, 47373-47379.
68. Medeiros, L. A., Khan, T., El Khoury, J. B., Pham, C. L., Hatters, D. M., Howlett, G. J., Lopez, R., O'Brien, K. D., and Moore, K. J. (2004) Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279, 10643-10648.
69. Maxeiner, H., Husemann, J., Thomas, C. A., Loike, J. D., El Khoury, J., and Silverstein, S. C. (1998) Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2. J. Exp. Med. 188, 2257-2265.
70. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., Takashima, Y., Kawabe, Y., Cynshi, O., Wada, Y., Honda, M., Kurihara, H., Aburatani, H., Doi, T., Matsumoto, A., Azuma, S., Noda, T., Toyoda, Y., Itakura, H., Yazaki, Y., and Kodama, T.; et al. (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-296. (Pubitemid 27142516)
71. Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., and El-Khoury, J. B. (2002) CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils. Am. J. Pathol. 160, 101-112.
72. Mucchiano, G. I., Haggqvist, B., Sletten, K., and Westermark, P. (2001) Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J. Pathol. 193, 270-275. (Pubitemid 32118140)
73. Vollmer, E., Brust, J., Roessner, A., Bosse, A., Burwikel, F., Kaesberg, B., Harrach, B., Robenek, H., and Bocker, W. (1991) Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels. Virchows Arch. A: Pathol. Anat. Histopathol. 419, 79-88.
74. Carter, R. S., Siegel, R. J., Chai, A. U., and Fishbein, M. C. (1987) Immunohistochemical localization of apolipoproteins A-I and B in human carotid arteries. J. Pathol. 153, 31-36.
75. Kunjathoor, V. V., Chiu, D. S., O'Brien, K. D., and LeBoeuf, R. C. (2002) Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22, 462-468.
76. O'Brien, K. D., Olin, K. L., Alpers, C. E., Chiu, W., Ferguson, M., Hudkins, K., Wight, T. N., and Chait, A. (1998) Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: Colocalization of biglycan with apolipoproteins. Circulation 98, 519-527. (Pubitemid 28371249)
77. Van Eck, M., Herijgers, N., Van Dijk, K. W., Havekes, L. M., Hofker, M. H., Groot, P. H., and Van Berkel, T. J. (2000) Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158fCys) on cholesterol levels and atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20, 119-127.
78. Basu, S. K., Brown, M. S., Ho, Y. K., Havel, R. J., and Goldstein, J. L. (1981) Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A. 78, 7545-7549.
79. Kayden, H. J., Maschio, F., and Traber, M. G. (1985) The secretion of apolipoprotein E by human monocyte-derived macrophages. Arch. Biochem. Biophys. 239, 388-395.
80. Kockx, M., Jessup, W., and Kritharides, L. (2008) Regulation of endogenous apolipoprotein E secretion by macrophages. Arterioscler. Thromb. Vasc. Biol. 28, 1060-1067.
81. Curtiss, L. K., and Boisvert, W. A. (2000) Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 11, 243-251.
82. Harris, J. D., Graham, I. R., Schepelmann, S., Stannard, A. K., Roberts, M. L., Hodges, B. L., Hill, V., Amalfitano, A., Hassall, D. G., Owen, J. S., and Dickson, G. (2002) Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein- E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE. Hum. Mol. Genet. 11, 43-58.
83. Shi, W., Wang, X., Wang, N. J., McBride, W. H., and Lusis, A. J. (2000) Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20, 2261-2266.
84. Boisvert, W. A., and Curtiss, L. K. (1999) Elimination of macrophage- specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice. J. Lipid Res. 40, 806-813.
85. Navab, M., Anantharamaiah, G. M., Reddy, S. T., and Fogelman, A. M. (2006) Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat. Clin. Pract. Cardiovasc. Med. 3, 540-547.
86. Bloedon, L., Dunbar, R., Duffy, D., Pinell-Salles, P., Norris, R., Degroot, B. J., Movva, R., Navab, M., Fogelman, A. M., and Rader, D. J. (2008) Safety, pharmacokinetics and pharmacodynamics of a single dose of oral apolipoprotein A-I mimetic peptide D-4F in high-risk cardiovascular patients. J. Lipid Res. 49, 1344-1352.